1. Home
  2. THRY vs PMN Comparison

THRY vs PMN Comparison

Compare THRY & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.83

Market Cap

114.8M

Sector

Industrials

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.01

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
PMN
Founded
2012
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.8M
115.5M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
THRY
PMN
Price
$3.83
$11.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.33
$42.67
AVG Volume (30 Days)
742.1K
39.2K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.29
52 Week High
$15.49
$27.40

Technical Indicators

Market Signals
Indicator
THRY
PMN
Relative Strength Index (RSI) 63.60 37.47
Support Level $3.46 $10.55
Resistance Level $4.05 $13.80
Average True Range (ATR) 0.29 0.84
MACD 0.07 0.18
Stochastic Oscillator 66.74 16.72

Price Performance

Historical Comparison
THRY
PMN

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: